$NBIO recognizes this patent approval as a landmark event for the Company's value proposition. The approval strengthens the Company's intellectual property position significantly by providing protection that extends well beyond the Company's Orphan Drug Designation. https://finance.yahoo.com/news/nascent-biotec...00301.html